hand-selected seven days a week

get news headlines delivered to your inbox each weekday

Bristol/Lilly: The Battle Begins
Forbes 7/25/08

Buyout or Sellout (Teva/Barr and Roche/Genentech)?
Motley Fool 7/25/08

Will Pfizer Pfizzle?
Motley Fool 7/25/08

Roche's Big Hurdle with Genentech
Businessweek 7/25/08

Elan says 2Q sales grow, forecasts MS drug to become $1 billion `blockbuster' soon
Yahoo/AP 7/25/08

Genentech Forms Special Committee of Independent Directors to Review Roche Proposal
Trading Markets 7/25/08

Turnabout: Teva
Forbes 7/25/08

Johnson & Johnson says FDA decision extends Topamax exclusivity by nearly a year
Yahoo/AP 7/25/08

Pharma Invests Big in Stem Cells
MIT Technology Review 7/25/08

Bristol touts 'great' second-quarter
Star Ledger, NJ 7/25/08

Pfizer's Valuation Metrics Show Limited Downside Risk
Seeking Alpha 7/25/08

Senator Sends Letter To Merck Over Co's Outsourcing
Easy Bourse, France 7/25/08

Barr challenges Cephalon pain-drug patent
Yahoo/AP 7/25/08

Bayer anticoagulant drug wins EU green light
Reuters 7/25/08

Taro: Sales Strong Despite Sun Fight
FDA News 7/25/08

FDA likely to rule soon on Vanda Pharmaceuticals drug approval
Bizjournals.com 7/25/08

Biotech stages a "strong comeback"
Yahoo/SmallCapInvestor 7/25/08

GSK signs transformational agreement with Aspen
Pharmaceutical Business Review 7/25/08

Watson Launches Omeprazole Delayed-Release Capsules, 40MG
Trading Markets 7/25/08

Ziopharm reports preliminary efficacy data from Phase I cancer trials
Pharmaceutical Business Review 7/25/08

Rise in drug prices boosts Medco's profit
Star Ledger, NJ 7/25/08

get news headlines delivered to your inbox each weekday

miss yesterday's headlines? check our archives

want these headlines on your site or company intranet?